Medical Benefit Specialty Drug Managementâ€“A Call to ActionFebruary 15th 2017
Specialty drug trend management typically focuses on drug formulations administered via a payer or plan sponsor pharmacy benefit, which overlooks drug spending occurring under a payer or plan sponsor medical benefit.
Specialty Drugs Year in Review Part II: Oncology Drugs and Late-breaking FDA ActionsFebruary 15th 2017
A comprehensive review of new oncology molecular entities and previously approved oncology drugs that received expanded indications in 2016, as well as drugs approved in the final days of the year.
HHS Guidance Requires Specialty Pharmacies to Scrutinize Patient Cost-Sharing and Incentive ProgramsFebruary 14th 2017
Specialty pharmacies will need to carefully consider the effect of the final rule regarding Anti-Kickback Statute safe harbors and Civil Monetary Penalty Law exceptions on their existing patient benefit programs.